GSEA showed that the high-risk group was significantly enriched in cancer-related signature pathways, including E2F TARGETS, G2M CHECKPOINT, IL6 JAK STAT3 SIGNALING, INFLAMMATORY RESPONSE, and MYC TARGETS V1 (FDR < 0.05, Fig 6A). This evidence concerns the gene MYC and cancer.